BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22952040)

  • 1. Incidence and clinical implications of ATM aberrations in chronic lymphocytic leukemia.
    Ouillette P; Li J; Shaknovich R; Li Y; Melnick A; Shedden K; Malek SN
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1125-32. PubMed ID: 22952040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion.
    Austen B; Skowronska A; Baker C; Powell JE; Gardiner A; Oscier D; Majid A; Dyer M; Siebert R; Taylor AM; Moss PA; Stankovic T
    J Clin Oncol; 2007 Dec; 25(34):5448-57. PubMed ID: 17968022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia.
    Schaffner C; Stilgenbauer S; Rappold GA; Döhner H; Lichter P
    Blood; 1999 Jul; 94(2):748-53. PubMed ID: 10397742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biallelic ATM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 trial.
    Skowronska A; Parker A; Ahmed G; Oldreive C; Davis Z; Richards S; Dyer M; Matutes E; Gonzalez D; Taylor AM; Moss P; Thomas P; Oscier D; Stankovic T
    J Clin Oncol; 2012 Dec; 30(36):4524-32. PubMed ID: 23091097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressive chronic lymphocytic leukemia with elevated genomic complexity is associated with multiple gene defects in the response to DNA double-strand breaks.
    Ouillette P; Fossum S; Parkin B; Ding L; Bockenstedt P; Al-Zoubi A; Shedden K; Malek SN
    Clin Cancer Res; 2010 Feb; 16(3):835-47. PubMed ID: 20086003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
    Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
    Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL.
    Austen B; Powell JE; Alvi A; Edwards I; Hooper L; Starczynski J; Taylor AM; Fegan C; Moss P; Stankovic T
    Blood; 2005 Nov; 106(9):3175-82. PubMed ID: 16014569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele.
    Skowronska A; Austen B; Powell JE; Weston V; Oscier DG; Dyer MJ; Matutes E; Pratt G; Fegan C; Moss P; Taylor MA; Stankovic T
    Haematologica; 2012 Jan; 97(1):142-6. PubMed ID: 21933854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptic deletion involving the ATM locus at 11q22.3 approximately q23.1 in B-cell chronic lymphocytic leukemia and related disorders.
    Eclache V; Caulet-Maugendre S; Poirel HA; Djemai M; Robert J; Lejeune F; Raphaël M
    Cancer Genet Cytogenet; 2004 Jul; 152(1):72-6. PubMed ID: 15193446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gene atm and chronic lymphocytic leukemia - review].
    Zhu DX; Xu W; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1242-6. PubMed ID: 18928637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare Germline
    Lampson BL; Gupta A; Tyekucheva S; Mashima K; Petráčková A; Wang Z; Wojciechowska N; Shaughnessy CJ; Baker PO; Fernandes SM; Shupe S; Machado JH; Fardoun R; Kim AS; Brown JR
    J Clin Oncol; 2023 Feb; 41(5):1116-1128. PubMed ID: 36315919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia.
    Xu W; Li JY; Wu YJ; Yu H; Shen QD; Li L; Fan L; Qiu HX
    Leuk Res; 2008 Jul; 32(7):1071-7. PubMed ID: 18035414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stage.
    Britt-Compton B; Lin TT; Ahmed G; Weston V; Jones RE; Fegan C; Oscier DG; Stankovic T; Pepper C; Baird DM
    Leukemia; 2012 Apr; 26(4):826-30. PubMed ID: 21986843
    [No Abstract]   [Full Text] [Related]  

  • 14. Linkage analysis for ATM in familial B cell chronic lymphocytic leukaemia.
    Bevan S; Catovsky D; Marossy A; Matutes E; Popat S; Antonovic P; Bell A; Berrebi A; Gaminara E; Quabeck K; Ribeiro I; Mauro FR; Stark P; Sykes H; van Dongen J; Wimperis J; Wright S; Yuille MR; Houlston RS
    Leukemia; 1999 Oct; 13(10):1497-500. PubMed ID: 10516748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage.
    Stankovic T; Stewart GS; Fegan C; Biggs P; Last J; Byrd PJ; Keenan RD; Moss PA; Taylor AM
    Blood; 2002 Jan; 99(1):300-9. PubMed ID: 11756185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study.
    Lozanski G; Ruppert AS; Heerema NA; Lozanski A; Lucas DM; Gordon A; Gribben JG; Morrison VA; Rai KM; Marcucci G; Larson RA; Byrd JC
    Leuk Lymphoma; 2012 Sep; 53(9):1743-8. PubMed ID: 22369572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATM mutations in B-cell chronic lymphocytic leukemia.
    Bullrich F; Rasio D; Kitada S; Starostik P; Kipps T; Keating M; Albitar M; Reed JC; Croce CM
    Cancer Res; 1999 Jan; 59(1):24-7. PubMed ID: 9892178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATM mutations are rare in familial chronic lymphocytic leukemia.
    Yuille MR; Condie A; Hudson CD; Bradshaw PS; Stone EM; Matutes E; Catovsky D; Houlston RS
    Blood; 2002 Jul; 100(2):603-9. PubMed ID: 12091354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ataxia telangiectasia gene mutations in leukaemia and lymphoma.
    Boultwood J
    J Clin Pathol; 2001 Jul; 54(7):512-6. PubMed ID: 11429421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATM gene alterations in chronic lymphocytic leukemia patients induce a distinct gene expression profile and predict disease progression.
    Guarini A; Marinelli M; Tavolaro S; Bellacchio E; Magliozzi M; Chiaretti S; De Propris MS; Peragine N; Santangelo S; Paoloni F; Nanni M; Del Giudice I; Mauro FR; Torrente I; Foà R
    Haematologica; 2012 Jan; 97(1):47-55. PubMed ID: 21993670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.